600+ sources. One page. See who else covered it.
The company is keeping costs in check while signaling upbeat growth trends, analysts say.
We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.
Spine and joint pain doesn't always have to end in surgery. Discover how regenerative medicine helps high performers repair joint and spinal tissues, restore function, and avoid invasive procedures.
Scotiabank strategists Shaun Osborne and Eric Theoret describe the Euro (EUR) as steady in the mid-to-lower 1.15 area, trading close to fair value based on 2-year US–Germany spreads.
The Municipal Chief Executive for Kwadaso, Eric Assibey, has cut the sod for the construction of the municipality’s 24-Hour Economy Market, describing it as a major step toward implementing the…
Some analysts see warning signs in crucial drug launches from Gilead and Merck, while an important trial readout could change Pfizer’s growth trajectory.
An anonymous reader quotes a report from Ars Technica: Several US senators have written a letter to the Commodity Futures Trading Commission (CFTC), inquiring about the agency's "plans to crack down…
The US unemployment rate was 4.2% in June, which is low by historical levels. Nonetheless, lot of workers, and perhaps expecially young workers right out of college, are experiencing the US economy as…